Skip to main content
Erschienen in: InFo Neurologie + Psychiatrie 7-8/2017

01.09.2017 | HIV | zertifizierte fortbildung

Immundefizienz und Nervensystem

Neurokognitive Defizite und Erkrankungen peripherer Nerven und Muskeln bei HIV

verfasst von: Prof. Dr. med. Gabriele Arendt

Erschienen in: InFo Neurologie + Psychiatrie | Ausgabe 7-8/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Unter der modernen antiretroviralen Kombinationstherapie (cART) haben sich Diagnostik und Therapie HIV-assoziierter Erkrankungen des Nervensystems verbessert. Nachdem man zur Kenntnis nehmen musste, dass auch bei effektiver Suppression der Viruslast im Blut neurokognitive Defizite sowie Erkrankungen des peripheren Nerven und Muskels auftreten können, wurden Screeningmethoden, diagnostische Schritte und Monitoringmethoden etabliert.
Literatur
1.
Zurück zum Zitat Insight START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV-Infection. N Engl J Med 2015;373:795–807CrossRef Insight START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV-Infection. N Engl J Med 2015;373:795–807CrossRef
2.
Zurück zum Zitat Joint United Nations Program on HIV/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic: Geneva: UNAIDS;2014 Joint United Nations Program on HIV/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic: Geneva: UNAIDS;2014
3.
Zurück zum Zitat Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003;17:1539–45.CrossRefPubMed Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003;17:1539–45.CrossRefPubMed
4.
Zurück zum Zitat Ellero J, Lubomski M, Brew B. Interventions for neurocognitive dysfunction. Curr HIV/AIDS Rep. 2017; 14(1):8–16.CrossRefPubMed Ellero J, Lubomski M, Brew B. Interventions for neurocognitive dysfunction. Curr HIV/AIDS Rep. 2017; 14(1):8–16.CrossRefPubMed
5.
Zurück zum Zitat Antinori A, Arendt G, Becker JT, Byrd DA Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin C, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna V. Updated research nosology for HIV-associated neurocognitive disorders (HAND). Neurology 2007; 69(18):1789–99CrossRefPubMedPubMedCentral Antinori A, Arendt G, Becker JT, Byrd DA Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin C, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna V. Updated research nosology for HIV-associated neurocognitive disorders (HAND). Neurology 2007; 69(18):1789–99CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Grant I, Franklin DR Jr., Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK; CHARTER Group. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 2014;82(23):2055–62.CrossRefPubMedPubMedCentral Grant I, Franklin DR Jr., Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK; CHARTER Group. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 2014;82(23):2055–62.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Cole H, Underwood J, Caan MW, De Francesco D, van Zoest RA, Leech R, Wit FW, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff MF, Franceschi C, Sabin CA, Majoie CB, Winston A, Reiss P, Sharp DJ, COBRA collaboration. Increased brain-predited aging in treated HIV disease. Neurology 03/2017; Epub ahead of print. Cole H, Underwood J, Caan MW, De Francesco D, van Zoest RA, Leech R, Wit FW, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff MF, Franceschi C, Sabin CA, Majoie CB, Winston A, Reiss P, Sharp DJ, COBRA collaboration. Increased brain-predited aging in treated HIV disease. Neurology 03/2017; Epub ahead of print.
8.
Zurück zum Zitat Watson C, Busovaca E, Foley JM, Allen IE, Schwarz CG, Jahanshad N, Nir TM, Esmaeili-Firidouni P, Milanini B, Rosen H, Carmichael OT, Thompson PM, Valcour VG. White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV. J Neurovirol 01/2017; Epub ahead of print. Watson C, Busovaca E, Foley JM, Allen IE, Schwarz CG, Jahanshad N, Nir TM, Esmaeili-Firidouni P, Milanini B, Rosen H, Carmichael OT, Thompson PM, Valcour VG. White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV. J Neurovirol 01/2017; Epub ahead of print.
9.
Zurück zum Zitat Spreen O und Strauss E. Controlled word association. A compendium of neuropsychological tests New York. Oxford University Press 2001;221-29. Spreen O und Strauss E. Controlled word association. A compendium of neuropsychological tests New York. Oxford University Press 2001;221-29.
10.
Zurück zum Zitat Golden CJ. Identification of brain disorders by the Stroop Colour and Word Test. J Clin Psychol 1976;32(3):654–58.CrossRefPubMed Golden CJ. Identification of brain disorders by the Stroop Colour and Word Test. J Clin Psychol 1976;32(3):654–58.CrossRefPubMed
11.
Zurück zum Zitat Reitan RM und Wolfson D. The Halstead-Reitan Neuropschological Test Battery. Tucson 1985, AZ: Neuropsychological Press. Reitan RM und Wolfson D. The Halstead-Reitan Neuropschological Test Battery. Tucson 1985, AZ: Neuropsychological Press.
12.
Zurück zum Zitat Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, Kirson DA, Grant I. Neuropsychological impairment in human immunodeficiency virus-infection:implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 1994;56(1):8–17.CrossRefPubMed Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, Kirson DA, Grant I. Neuropsychological impairment in human immunodeficiency virus-infection:implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 1994;56(1):8–17.CrossRefPubMed
13.
Zurück zum Zitat Smith A. Symbol Digit Modalities Test (SDMT). Manual (revised). 1982. Los Angeles: Western Psychological Services. Smith A. Symbol Digit Modalities Test (SDMT). Manual (revised). 1982. Los Angeles: Western Psychological Services.
14.
Zurück zum Zitat Wechsler D. Wechsler Memory Scale. Third Ed. Manual. 1997. San Antonio, TX: The Psychological Corporation. Wechsler D. Wechsler Memory Scale. Third Ed. Manual. 1997. San Antonio, TX: The Psychological Corporation.
15.
Zurück zum Zitat Benedict RHB, Schretlen D et al. Hopkins Verbal Learning Test Revised: Normative data and analysis of inter-form and test retest reliability. Clinical Neuropsychologist 1998;12:787–805. Benedict RHB, Schretlen D et al. Hopkins Verbal Learning Test Revised: Normative data and analysis of inter-form and test retest reliability. Clinical Neuropsychologist 1998;12:787–805.
16.
Zurück zum Zitat Heaton RK, Miller SW et al. Revised Comprehensive Norms for an expanded Halstead-Reitan Battery: Demographically Adjusted Norms for African American and Caucasian Adults. Lutz 2004, FL: Psychological Assesment Resources, Inc. Heaton RK, Miller SW et al. Revised Comprehensive Norms for an expanded Halstead-Reitan Battery: Demographically Adjusted Norms for African American and Caucasian Adults. Lutz 2004, FL: Psychological Assesment Resources, Inc.
17.
Zurück zum Zitat Klove H. The medical clinics of North America. Clinical Neuropsychology F.M. Foster Ed. 1963. Klove H. The medical clinics of North America. Clinical Neuropsychology F.M. Foster Ed. 1963.
18.
Zurück zum Zitat McNair DM und Kahn. The Cognitive Difficulties Scale. 1984. McNair DM und Kahn. The Cognitive Difficulties Scale. 1984.
19.
Zurück zum Zitat Chelune GJ, Heaton RK et al. Patients’ complaints of disability: their role in neuropsychological assessment. Psychotherapy in Private Practice 1986;4:45–50. Chelune GJ, Heaton RK et al. Patients’ complaints of disability: their role in neuropsychological assessment. Psychotherapy in Private Practice 1986;4:45–50.
20.
Zurück zum Zitat Mind Exchange Working Group. Assessment, diagnosis and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis 2013;56:1004–17CrossRef Mind Exchange Working Group. Assessment, diagnosis and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis 2013;56:1004–17CrossRef
21.
Zurück zum Zitat Kamminga J, Block M., Vincent T, Carberry A, Brew BJ, Cysique LA. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure. J Clin Exp Neuropsychol 2017;18(5):363-69 Epub ahead of print. Kamminga J, Block M., Vincent T, Carberry A, Brew BJ, Cysique LA. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure. J Clin Exp Neuropsychol 2017;18(5):363-69 Epub ahead of print.
22.
Zurück zum Zitat Motta I, Allice T, Romito A, Ferrara M, Ecclesia S, Imperiale D, Ghisetti V, Di Perri G, Bonora S, Calcagno A. Cerebrospinal fluid viral load and neopterine in HIV-positive patients with undetectable viremia. Antivir Ther. 02/2017; Epub ahead of print. Motta I, Allice T, Romito A, Ferrara M, Ecclesia S, Imperiale D, Ghisetti V, Di Perri G, Bonora S, Calcagno A. Cerebrospinal fluid viral load and neopterine in HIV-positive patients with undetectable viremia. Antivir Ther. 02/2017; Epub ahead of print.
23.
Zurück zum Zitat Tiraboschi JM, Niubo J, Vila A, Perez-Pujol S, Podzamczer D. Etravirine concentrations in CSF in HIV-infected patients. J Antimicrob Chemother 2012;67(6):1446–48CrossRefPubMed Tiraboschi JM, Niubo J, Vila A, Perez-Pujol S, Podzamczer D. Etravirine concentrations in CSF in HIV-infected patients. J Antimicrob Chemother 2012;67(6):1446–48CrossRefPubMed
24.
Zurück zum Zitat Nguyen A, Rossi St, Croteau D, Best BM, Clifford D, Collier AC, Gelman B, Marra C, McArthur J, McCutchan JA. Etravirine in CSF is highly protein bound. J Antimicrob Chemother 2013;68(5):1161–68CrossRefPubMedPubMedCentral Nguyen A, Rossi St, Croteau D, Best BM, Clifford D, Collier AC, Gelman B, Marra C, McArthur J, McCutchan JA. Etravirine in CSF is highly protein bound. J Antimicrob Chemother 2013;68(5):1161–68CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Mora-Peris B, Watson V, Vera JH, Weston R, Waldman AD, Kaye S, Khoo S, Mackie NE, Back D, Winston A. Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy. J Antimicrob Chemother 2014;69(6):1642–47CrossRefPubMed Mora-Peris B, Watson V, Vera JH, Weston R, Waldman AD, Kaye S, Khoo S, Mackie NE, Back D, Winston A. Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy. J Antimicrob Chemother 2014;69(6):1642–47CrossRefPubMed
26.
Zurück zum Zitat Letendre et al. CROI 2013;Abstract 178 LB Letendre et al. CROI 2013;Abstract 178 LB
27.
Zurück zum Zitat Turchan J, Sacktor N, Wojna V, Conant K, Nath A. Neuroprotective Therapy for HIV dementia. Darr HIV Res 2003; 1:378–83. Turchan J, Sacktor N, Wojna V, Conant K, Nath A. Neuroprotective Therapy for HIV dementia. Darr HIV Res 2003; 1:378–83.
29.
Zurück zum Zitat Hahn K, Maschke M, Eggers C, Husstedt IW, Arendt G. Update HIV und Neurologie. Dtsch med. Wochenschr 2016;141(1):51–57.PubMed Hahn K, Maschke M, Eggers C, Husstedt IW, Arendt G. Update HIV und Neurologie. Dtsch med. Wochenschr 2016;141(1):51–57.PubMed
Metadaten
Titel
Immundefizienz und Nervensystem
Neurokognitive Defizite und Erkrankungen peripherer Nerven und Muskeln bei HIV
verfasst von
Prof. Dr. med. Gabriele Arendt
Publikationsdatum
01.09.2017
Verlag
Springer Medizin
Schlagwörter
HIV
Immundefekte
Erschienen in
InFo Neurologie + Psychiatrie / Ausgabe 7-8/2017
Print ISSN: 1437-062X
Elektronische ISSN: 2195-5166
DOI
https://doi.org/10.1007/s15005-017-2080-x

Weitere Artikel der Ausgabe 7-8/2017

InFo Neurologie + Psychiatrie 7-8/2017 Zur Ausgabe